December 10, 2014
Webinar
The requirements for inventive step in Europe and non-obviousness in the United States have many similarities but also some subtle differences. The challenges faced by different technologies can also vary for inventive step and obviousness. In most cases, you might expect to use similar tactics and obtain similar results, but some cases require different approaches and can end up with very different outcomes. With global patenting strategies, companies often struggle to ensure consistency when prosecuting applications to grant in both jurisdictions and within different technologies.
Following on Finnegan’s inventive step vs. obviousness webinar from earlier this year, which gave an overview of both proceedings, this sequel will focus on industry and technology specific examples and practical advice. We will discuss detailed examples within a variety of industries including biotechnology, chemical, pharmaceutical, electrical and mechanical.
Discussion topics will include:
Speakers:
Bryan C. Diner
Leythem A. Wall
Date:
Wednesday, December 14, 2014
15:00 - 16:00 GMT
16:00 - 17:00 CET
10:00 a.m. - 11:00 a.m. EST
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.